drugset / Trial / NCT04161690

Evaluation of Dexketoprofen in Total Knee Arthroplasty

NCT04161690

Phase 2 Unknown 120 enrolled KAT General Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Pain is a global public health issue and represents the most common reason for both physician consultation and hospital admissions. Dexketoprofen is a new NSAID treating acute postoperative pain. The purpose of this study is to evaluate the analgesic effect when it is given intravenously or as part of the local infiltration analgesia in patients under spinal anesthesia undergoing unilateral total knee arthroplasty.

Timeline

Start
2019-11-06
Primary completion
2020-11-30
Completion
2021-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexketoprofen Small molecule 50 mg Intravenous
Comparator Ropivacaine Other / unclassified 300 mg Other

Indications

No indication recorded.